EligibleTrials

PAS 1ml Magtrace® for Sentinel Lymph Node Biopsy in Breast Cancer Patients

Recruiting · NCT06610539 · Observational (researchers observe without assigning treatment) · Lead sponsor: Endomagnetics Ltd.

View the official record on ClinicalTrials.gov →
Breast Cancer

What this trial is about

The purpose of this study is to provide prospective evidence in the US population of the frequency of skin discoloration and Sentinel Lymph Node detection rate in patients who have recevied Magtrace for Sentinel Lymph Node Biopsy (SLNB) and to evaluate the impact that skin discoloration has on patients when it does occur using patient reported outcome measures.

Who can take part

Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)

Inclusion criteria

Exclusion criteria

Where it is running

2 locations listed across 2 US states.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.